AH amyloid neuropathy: a novel clinical phenotype confirmed by histopathology and mass spectrometry
Amyloid
.
2022 Jun;29(2):141-142.
doi: 10.1080/13506129.2022.2049745.
Epub 2022 Mar 14.
Authors
Nobuhiko Ohashi
1
,
Nagaaki Katoh
2
,
Kazuki Kasuga
1
,
Tsuneaki Yoshinaga
1
,
Fuyuki Kametani
3
,
Masahide Yazaki
4
5
,
Yoshiki Sekijima
1
5
Affiliations
1
Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
2
Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
3
Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
4
Clinical Laboratory Sciences Division, Shinshu University Graduate of School of Medicine, Matsumoto, Japan.
5
Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan.
PMID:
35285361
DOI:
10.1080/13506129.2022.2049745
No abstract available
Publication types
Letter
MeSH terms
Amyloid Neuropathies* / diagnosis
Amyloid Neuropathies* / genetics
Amyloid Neuropathies* / pathology
Humans
Mass Spectrometry
Phenotype